IRIS
TEDESCHI, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 574
NA - Nord America 233
EU - Europa 232
SA - Sud America 173
AF - Africa 31
OC - Oceania 1
Totale 1.244
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 219
US - Stati Uniti d'America 209
BR - Brasile 127
IT - Italia 109
CN - Cina 108
VN - Vietnam 99
HK - Hong Kong 44
DE - Germania 25
FI - Finlandia 20
FR - Francia 19
BD - Bangladesh 18
IN - India 18
AR - Argentina 15
GB - Regno Unito 13
KR - Corea 13
ZA - Sudafrica 11
MX - Messico 10
EC - Ecuador 9
IQ - Iraq 8
CA - Canada 7
CZ - Repubblica Ceca 7
RU - Federazione Russa 7
TR - Turchia 7
UA - Ucraina 7
ID - Indonesia 6
MA - Marocco 6
VE - Venezuela 6
PE - Perù 5
PL - Polonia 5
DZ - Algeria 4
ES - Italia 4
NL - Olanda 4
PH - Filippine 4
PY - Paraguay 4
CL - Cile 3
EG - Egitto 3
JO - Giordania 3
KZ - Kazakistan 3
SA - Arabia Saudita 3
TN - Tunisia 3
UZ - Uzbekistan 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CO - Colombia 2
HN - Honduras 2
JP - Giappone 2
MY - Malesia 2
PK - Pakistan 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BG - Bulgaria 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
IE - Irlanda 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
KG - Kirghizistan 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
QA - Qatar 1
SE - Svezia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UY - Uruguay 1
Totale 1.244
Salva come PNG Salva come JPEG
Città #
Singapore 99
Florence 71
San Jose 53
Hong Kong 44
Hanoi 29
Boardman 23
Hefei 23
Beijing 21
Ho Chi Minh City 21
Ashburn 19
Dallas 18
Lauterbourg 13
Seoul 13
Helsinki 12
Munich 12
Haiphong 11
Noto 10
Sesto Fiorentino 10
Los Angeles 9
São Paulo 8
New York 6
Santa Clara 6
Dhaka 5
Falkenstein 5
Johannesburg 5
Rio de Janeiro 5
Rome 5
Shanghai 5
Turku 5
Warsaw 5
Brooklyn 4
Da Nang 4
Frankfurt am Main 4
London 4
Porto Alegre 4
Secaucus 4
Wuhan 4
Amman 3
Baghdad 3
Buffalo 3
Council Bluffs 3
Guangzhou 3
Lappeenranta 3
Mexico City 3
Montreal 3
Nova Iguaçu 3
Riyadh 3
Zibo 3
Astana 2
Asunción 2
Belo Horizonte 2
Bologna 2
Brasília 2
Bucharest 2
Buenos Aires 2
Bắc Giang 2
Can Tho 2
Caruaru 2
Catania 2
Charlotte 2
Chennai 2
Cleveland 2
Curitiba 2
Giza 2
Goiânia 2
Guarulhos 2
Houston 2
Itabira 2
Itajaí 2
Kyiv 2
Lima 2
Lviv 2
Manama 2
Monastir 2
Montes Claros 2
Mumbai 2
Natal 2
Ninh Bình 2
Ogden 2
Phoenix 2
Quito 2
Recife 2
Rende 2
Salvador 2
San Cristóbal 2
Santiago 2
Seattle 2
Sumaré 2
Surabaya 2
Surat 2
São Bernardo do Campo 2
São Vicente 2
Tangier 2
Tashkent 2
Thái Nguyên 2
Tây Ninh 2
Valencia 2
Aarhus 1
Abidjan 1
Al Ain City 1
Totale 733
Salva come PNG Salva come JPEG
Nome #
Preexisting and treatment-emergent autoimmune cytopenias in patients with CLL treated with targeted drugs 103
Coexisting conditions and concomitant medications do not affect venetoclax management and survival in chronic lymphocytic leukemia 100
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study 97
Use of BTK inhibitors with special focus on ibrutinib in Waldenström macroglobulinemia: An expert panel opinion statement 96
Prognostic Impact and Risk Factors of Infections in Patients with Chronic Lymphocytic Leukemia Treated with Ibrutinib 94
Use of BTK inhibitors with focus on ibrutinib in mantle cell lymphoma: An expert panel opinion statement 86
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature 81
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real‐life multicenter Italian cohort 80
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 77
Kinetics of lymphocytosis in naïve chronic lymphocytic leukemia patients treated with covalent Bruton's tyrosine kinase inhibitors: An Italian multicenter real‐life experience 73
Venetoclax based regimens in octogenarian CLL patients: efficacy, safety and comparison to BTKi in a multicenter cohort 73
Prediction of outcomes in chronic lymphocytic leukemia patients treated with ibrutinib: Validation of current prognostic models and development of a simplified three-factor model 73
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study 63
Rethinking the feasibility and safety of venetoclax-obinutuzumab in chronic lymphocytic leukemia: non-traditional factors may play a role in clinical practice 62
Acalabrutinib in High‐Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real‐Life Experience 59
Clinical Frailty Scale as a Predictor of Early Treatment Discontinuation in Elderly Patients With Chronic Lymphocytic Leukemia Treated With Zanubrutinib: A Multicenter Real‐World Study 34
Real-World Safety and Effectiveness of Zanubrutinib versus Ibrutinib in CLL: The CLL-ZANU2024 Italian Cohort 13
Totale 1.264
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.601
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.601
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/202331 0 0 0 0 0 0 14 3 0 2 9 3
2023/2024119 0 2 24 34 11 13 10 5 3 1 1 15
2024/2025255 16 22 0 12 24 21 7 4 18 20 32 79
2025/2026859 113 47 46 83 177 55 122 49 73 94 0 0
Totale 1.264